| 2025-02-14 | -0.81 % |
|
| 2025-02-13 | +3.76 % |
|
| 2025-02-12 | -4.28 % |
- Biogen (BIIB) stock fell by 4.28% following mixed analyst ratings, including a downgrade from BMO Capital Markets that reduced its price target from $230 to $164, contributing to a generally negative sentiment among investors.
- Biogen (BIIB) stock declined by 4.28% amid a broader market downturn driven by a hotter-than-expected inflation reading for January, which led investors to reassess expectations for Federal Reserve interest rate cuts in 2025.
- Biogen (BIIB) stock fell by 4.28% after the company exceeded fourth-quarter earnings and sales expectations but provided a disappointing earnings outlook for 2025.
- Biogen (BIIB) stock fell 4.28% following a forecast for 2025 profits that fell short of Wall Street expectations, primarily due to the impact of a strong dollar and increased competition for its multiple sclerosis treatments.
- The article primarily discusses Biogen's (BIIB) stock performance, noting a decline of 4.28% without detailing the specific reasons for this drop; however, context from other financial news suggests that such movements could be due to various macroeconomic factors, earnings forecasts, or changes in analyst ratings that might negatively impact investor sentiment.
- Biogen (NASDAQ: BIIB) stock fell 4.28% primarily due to multiple analysts including TD Cowen and Needham & Company downgrading their ratings and cutting the price targets for the stock, reflecting a less optimistic outlook on the company's performance.
- Biogen (BIIB) stock fell by 4.28% due to investor concerns about competition and the relative strength of alternative investment opportunities, particularly highlighted by the potential upside of BioCardia compared to Biogen in the context of other small-cap medical companies.
|
| 2025-02-11 | -2.21 % |
|
| 2025-02-07 | -0.72 % |
|
| 2025-02-06 | -2.17 % |
|
| 2025-02-05 | +2.13 % |
|
| 2025-02-04 | +0.11 % |
|
| 2025-01-31 | -1.57 % |
|
| 2025-01-28 | -2.2 % |
|
| 2025-01-27 | +1.75 % |
|
| 2025-01-22 | +1.26 % |
|
| 2025-01-16 | +0.16 % |
|
| 2025-01-15 | -1.44 % |
|
| 2025-01-14 | -4.74 % |
|
| 2025-01-13 | +0.91 % |
|
| 2025-01-10 | -1.28 % |
|
| 2025-01-06 | +0.7 % |
|
| 2025-01-02 | -1.91 % |
|
| 2024-12-30 | -0.74 % |
|
| 2024-12-24 | -0.24 % |
|
| 2024-12-23 | +1.99 % |
|
| 2024-12-19 | +0.41 % |
|
| 2024-12-17 | +0.1 % |
|
| 2024-12-09 | -0.84 % |
|
| 2024-12-04 | +0.04 % |
|
| 2024-11-27 | +1.36 % |
|
| 2024-11-26 | -0.64 % |
|
| 2024-11-25 | +0.51 % |
|
| 2024-11-20 | +0.37 % |
|
| 2024-11-18 | -1.28 % |
|
| 2024-11-13 | -1.48 % |
|
| 2024-11-11 | -0.58 % |
|
| 2024-11-07 | -0.28 % |
|
| 2024-11-06 | -1.43 % |
|
| 2024-11-05 | +1.97 % |
|
| 2024-11-04 | -0.16 % |
|
| 2024-10-31 | -3.96 % |
|
| 2024-10-30 | -1.25 % |
|
| 2024-10-29 | -0.83 % |
|
| 2024-10-28 | +1.83 % |
|
| 2024-10-23 | -1.57 % |
|
| 2024-10-21 | -2.9 % |
|
| 2024-10-18 | +0.32 % |
|
| 2024-10-17 | +0.29 % |
|
| 2024-10-15 | -0.01 % |
|
| 2024-10-14 | +1.69 % |
|
| 2024-10-11 | -0.11 % |
|
| 2024-10-10 | +1.52 % |
|
| 2024-10-08 | -0.57 % |
|
| 2024-10-04 | +0.49 % |
|
| 2024-10-03 | -2.1 % |
|
| 2024-10-02 | -1.08 % |
|
| 2024-09-27 | +0.55 % |
|
| 2024-09-25 | -2.6 % |
|
| 2024-09-24 | -0.86 % |
|
| 2024-09-20 | -1.03 % |
|
| 2024-09-17 | -0.69 % |
|
| 2024-09-13 | -1.14 % |
|
| 2024-09-11 | -0.77 % |
|
| 2024-09-09 | -0.77 % |
|
| 2024-08-30 | -0.03 % |
|
